Review of Blood Pressure Lowering-Benefits of Physical Activity, Weight-Loss and Dietary Modifications in Blood Pressure Control among US Minority Communities
DOI:
https://doi.org/10.12970/2310-998X.2014.02.02.4Keywords:
African Americans, other US minorities, hypertension, comorbid conditions, primary & secondary preventions.Abstract
Background: Hypertension develops in individuals irrespective of age, gender, national origin or ethnic grouping. However, there are some differences regarding the extent to which each ethnic population distribution is involved. This review utilized the Health Belief Model (HBM) to design an approach to promote knowledge, beliefs, and modify health behavior of African-Americans with borderline high blood pressure risk factors toward hypertension.
Methods: To meet the study objectives, we searched MEDLINE from January 2011 through December 2013, using the medical subject headings of physical activity and health, nutrition, exercise/leisure-time activity, hypertension, stroke, and cardiovascular disease. Twenty-five peer-reviewed scientific articles which met our research inclusion criteria were identified and reviewed.
Results: On overweight, obesity and sedentary lifestyles, as comorbid factors for hypertension and other CVDs, many researchers concluded that the combination of excessive nutrient intake and sedentary lifestyle has been the major causes for the rapid acceleration of obesity in today’s US population. While hypertension is more prevalent and severer in African Americans than other US populations, these authors believe that the major process in high blood pressure control, therefore, lies in the concept of primary and secondary prevention interventions involving sustained efforts in behavior, lifestyle changes, and therapeutic compliance via the HBM at the pre-hypertension stage.
Conclusion: The risk of hypertension in the US general population and its unabated disproportional representation in minority communities, especially African Americans, remains a major health challenge. Hence, reviewing and understanding research studies on hypertension, behavioral risk factors and lifestyle changes may prove useful and beneficial for high blood pressure and comorbid conditions intervention programs.
References
Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertension 2003; 21: 875-76. http://dx.doi.org/10.1097/00004872-200305000-00011
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72. http://dx.doi.org/10.1001/jama.289.19.2560
CDC. State-specific trends in self-reported blood pressure screening and high blood pressure—United States, 1991-1999. MMWR 2002; 51: 456-460.
Vasan RS, Beiser A, Seshadri S. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. J Am Med Assoc 2002; 287: 1003-10. http://dx.doi.org/10.1001/jama.287.8.1003
Thom T, Hasse N, Rosamond W. Heart disease and stroke statistics: 2006 update. A report from the American Heart Association Committee and Smoke Statistics Subcommittee. Circulation 2006; 287: 85-151. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.171600
Elliott WJ. Management of hypertension in the very elderly patient. Hypertension 2004; 44: 800-804. http://dx.doi.org/10.1161/01.HYP.0000146909.69161.8c
National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. Obesity Res 1998; 6(suppl 2): 51S-209S [Published erratum appears in Obes Res 1998; 6: 464]. Retrieved February 2008 from: http://www.nhlbi.nih.gov/ guidelines/obesity/ob_home.htm
Barlow SE, Dietz WH. Obesity evaluation and treatment: expert committee recommendations. Pediatrics 1998; 102: E29. Retrieved February 2008 from: http://www.pediatrics. org/cgi/content/full/102/3/e29
Thomas PR. Weighing the options: criteria for evaluating weight-management programs. Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity, Institute of Medicine. Washington, D.C.: National Academy Press 1995. http://dx.doi.org/10.1037/10510-000
Centers for Disease Control. Racial/Ethnic Disparities in Prevalence, Treatment, and Control of Hypertension --- United States, 1999-2002. MMWR. January 14, 2005; 54(01): 7-9.
Lyznicki JM, Young DC, Riggs JA, Davis RM. Obesity: Assessment and management in primary care. J Am Family Physicians 2001; 63(11).
Centers for Disease Control & Prevention. Health disparities experienced by racial/ethnic minority populations. MMWR 2004; 53: 755, CDC. Health disparities experienced by Hispanics---United States. MMWR 2004; 53: 935-7.
Nesbitt SD. Hypertension in Black patients: Special issues and considerations. Curr Cardiol Rep 2004; 6(6): 416-20. http://dx.doi.org/10.1007/s11886-004-0048-1
Polit DF, Beck CT. Nursing Research: Principles and Methods (7th Edition). Philadelphia, PA: Lipincott Williams & Wilkins 2004.
Glanz K, Rimer BK, Lewis FM. Health Behavior & Health Education: Theory, Research and Practice. San Francisco, CA, Jossey-Bass, Inc.; 2005.
Bandura A. Self-Efficacy: The Exercise of Control. New York: W. H. Freeman & Company 1997.
Reusser ME, McCarron DA. Reducing hypertensive cardiovascular disease risk of African Americans with diet: focus on the facts. J Nutr 2006; 136(4): 1099-102.
Centers for Disease Control, Physical Activity and Health: A Report of the Surgeon General. Washington DC: US Dept. of Health & Human Services 1996. http://www.cdc.gov/ nccdphp/sgr/contents.htm. Retrieved March 20, 2008.
US Dept. of Health & Human Services. Healthy People 2010, conference ed., 2 vols. Washington DC: US Public Health Service; January 2000. Publication PHS # 017- 001-00547-9.
Sandhu JS, Berri A, Gupta D, Arya M, Singh R, Sandhu P. Essential Hypertension – Primary Prevention. J Indian Acad Clin Med 2004; 5(4): 306-309.
Bray GA. Risk of obesity. Endocrinol. Metab Clin N Am 2003; 32: 787-804. http://dx.doi.org/10.1016/S0889-8529(03)00067-7
Vasan RS, Larson MG, Lei EP, et al. Assessment of frequency of progression in non hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-6. http://dx.doi.org/10.1016/S0140-6736(01)06710-1
American Association of Clinical Endocrinologists (ACCE). Medical Guidelines for Clinical Practice, diagnosis & treatment of Hypertension 2006; 12(2): 197-202.
Ebrahim S, Smith GD. Lowering blood pressure: a systemic review of sustained; effects of non-pharmacological interventions. J Public Health Med1998; 20: 441-48.
Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure: meta- analysis of randomized, controlled clinical trials. JAMA 1997; 277: 1624-32. http://dx.doi.org/10.1001/jama.1997.03540440058033
Krouse-Wood MA, Muntner P, He J, Whelton PK. Primary prevention of essential hypertension. Med Clin N Am 4004; 88: 223-38.
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-SODIUM Collaborative Research Group. New Engl J Med 2001; 344: 3-10. http://dx.doi.org/10.1056/NEJM200101043440101
American consensus statement of Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003; 163: 525-41.
He J, Whelton PK. Role of sodium reduction in the treatment and prevention of hypertension [review]. Cirr Opin Cardiol 1997; 12: 202-7. http://dx.doi.org/10.1097/00001573-199703000-00018
Cutler JA, Follman D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997; 65(suppl 2): 643s-51s.
Vasan RS, Beiser A, Sheshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287: 1003-10. http://dx.doi.org/10.1001/jama.287.8.1003
Whelton PK, Appel LJ, Espeland MA, et al. (TONE Collaborative Research Group). Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE) [erratum in JAMA. 1998; 279:1954]. JAMA 1998; 279: 839-46. http://dx.doi.org/10.1001/jama.279.11.839
Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624-32. http://dx.doi.org/10.1001/jama.1997.03540440058033
Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998; 98: 1198-204. http://dx.doi.org/10.1161/01.CIR.98.12.1198
Hypertension control: report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1996; 862: 1-83.
The effects of nonpharmacological interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I [erratum in JAMA. 1992; 267: 2330]. JAMA 1992; 267: 1213-20. http://dx.doi.org/10.1001/jama.1992.03480090061028
Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 1996; 124: 825-31. http://dx.doi.org/10.7326/0003-4819-124-9-199605010-00007
Appel LJ, Moore TJ, Obarzanek E, et al. (DASH Collaborative Research Group). A clinical trial of the effects of dietary patterns on blood pressure. N England J Med 1997; 336: 1117-24. http://dx.doi.org/10.1056/NEJM199704173361601
Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999; 159: 285-93. http://dx.doi.org/10.1001/archinte.159.3.285
Bucher HC, Cook RJ, Gyatt GH, et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 1016-22. http://dx.doi.org/10.1001/jama.1996.03530370054031
Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled clinical trials. Circulation 1993; 88: 553-33. http://dx.doi.org/10.1161/01.CIR.88.2.523
Jee SH, He J, Whelton PK, et al. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999; 33: 1647-55. http://dx.doi.org/10.1161/01.HYP.33.2.647
Obarzanek E, Velletri PA, Cutler JA. Dietary protein and blood pressure. JAMA 1996; 275: 1598-603. http://dx.doi.org/10.1001/jama.1996.03530440078040
National Institutes of Health. JNC-Seventh Report of the Joint Commission on Prevention, Detection, Evaluation and treatment of High Blood Pressure 2005; US Department of Health & Human Services, Washington D.C.
Kailasam MT, O’Connor DT, Parmer RJ. Hereditary intermediate phenotypes in African American hypertension. Ethnicity Health 1996; 1(2): 117-28. http://dx.doi.org/10.1080/13557858.1996.9961778
Adrogué HJ, Madias NE. Sodium and Potassium in the Pathogenesis of Hypertension. N Engl J Med 2007; 356: 1966-78. http://dx.doi.org/10.1056/NEJMra064486
Stevens VJ, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention phase II. Ann Internal Med 2001; 134: 1. http://dx.doi.org/10.7326/0003-4819-134-1-200101020-00007
Edlin, Gordon, and Eric Golanty. Health and wellness, 11th edition. Jones & Bartlett Publishers, 2014; 319.
Douglas, Janice G, et al. "Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Inter Med 2003; 163.5: 525.
